Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3556 AL 3570

Transcranial direct current stimulation for Parkinson's disease: systematic review and meta-analysis of motor and cognitive effects

Duan Z, Zhang C.

NPJ Parkinsons Dis. 2024 Nov 6;10(1):214. doi: 10.1038/s41531-024-00821-z.

PINK1 knockout rats show premotor cognitive deficits measured through a complex maze

Soto I, Nejtek VA, Siderovski DP, Salvatore MF.

bioRxiv [Preprint]. 2024 Jan 19:2024.01.18.576285. doi: 10.1101/2024.01.18.576285.

Editorial: Advancements of deep learning in medical imaging for neurodegenerative diseases

Gaur L, Siarry P, Abraham A, Castillo O.

Front Neurosci. 2024 Jan 19;18:1361055. doi: 10.3389/fnins.2024.1361055. eCollection 2024.

The association between age-related macular degeneration and risk of Parkinson disease: A systematic review and meta-analysis

Meng M, Shen X, Xie Y, Wang J, Liu J.

Medicine (Baltimore). 2024 Nov 15;103(46):e40524. doi: 10.1097/MD.0000000000040524.

Trends on Novel Targets and Nanotechnology-Based Drug Delivery System in the Treatment of Parkinson's disease: Recent Advancement in Drug Development

Majumdar M, Badwaik H.

Curr Drug Targets. 2024;25(15):987-1011. doi: 10.2174/0113894501312703240826070530.

Expanded and independent validation of the NoMoFA scale for Parkinson's disease: the Italian version

Balestrino R, Rinaldi D, Galli S, Romagnolo A, Erro R, Ledda C, Donzuso G, Picillo M, Terravecchia C, Agosta F, Barone P, Lopiano L, Nicoletti A, Filippi M, Martinez-Martin P, Artusi CA.

J Neurol. 2024 Dec 28;272(1):89. doi: 10.1007/s00415-024-12863-7.

Editorial: Reviews in emotional and behavioral dyscontrol in neurological disorders

Tan T, Palumbo S.

Front Behav Neurosci. 2024 Jul 22;18:1447287. doi: 10.3389/fnbeh.2024.1447287. eCollection 2024.

Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?

Savoie FA, Arpin DJ, Vaillancourt DE.

Curr Neuropharmacol. 2024;22(10):1583-1605. doi: 10.2174/1570159X21666230801140648.

Short-term lipopolysaccharide treatment leads to astrocyte activation in LRRK2 G2019S knock-in mice without loss of dopaminergic neurons

Ngo HKC, Le H, Ayer SJ, Crotty GF, Schwarzschild MA, Bakshi R.

Res Sq [Preprint]. 2024 Mar 21:rs.3.rs-4076333. doi: 10.21203/rs.3.rs-4076333/v1.

Neuroprotective Efficacy of the Glucocorticoid Receptor Modulator PT150 in the Rotenone Mouse Model of Parkinson's Disease

Latham AS, Rocha SM, McDermott CP, Reigan P, Slayden RA, Tjalkens RB.

bioRxiv [Preprint]. 2024 Apr 15:2024.04.12.589261. doi: 10.1101/2024.04.12.589261.

Effects of nonimmersive virtual reality using Wii-Fit exercises on balance and cognition in Parkinson disease: A meta-analysis

Hussain F, Farooqui S, Khan AA, Khan MU, Khan MA, Hasan A.

Medicine (Baltimore). 2024 Jul 26;103(30):e38940. doi: 10.1097/MD.0000000000038940.

Devices for remote continuous monitoring of people with Parkinson's disease: a systematic review and cost-effectiveness analysis

Cox E, Wade R, Hodgson R, Fulbright H, Phung TH, Meader N, Walker S, Rothery C, Simmonds M.

Health Technol Assess. 2024 Jul;28(30):1-187. doi: 10.3310/YDSL3294.

Risk of Parkinson's disease among users of alpha-adrenergic receptor antagonists: a systematic review and meta-analysis

Lamichhane P, Tariq A, Akhtar AN, Raza M, Lamsal AB, Agrawal A.

Ann Med Surg (Lond). 2024 May 6;86(6):3409-3415. doi: 10.1097/MS9.0000000000002117. eCollection 2024 Jun.

Special Issue: Non-Pharmacological Interventions for People with Parkinson's Disease: Are We Entering a New Era?

Kalbe E, Bloem BR, Kalia LV, Nieuwboer A.

J Parkinsons Dis. 2024;14(s1):S1-S4. doi: 10.3233/JPD-249009.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias